Follow @keithspeights
Recent articles
Is It Time to Worry About Charlotte's Web?
Two recent developments have heightened investors' anxiety about the CBD stock. Are the worries overblown?
Why Kodiak Sciences Stock Is Jumping Today
Momentum continues from the drugmaker's royalty deal announced earlier this week despite a big public stock offering.
Why Ardelyx Shares Jumped Today
Investors reacted positively to the drugmaker's late-stage clinical results.
Why Cara Therapeutics Stock Is Plunging Today
Investors aren't happy with the company's mixed results from a midstage study of Oral Korsuva.
Aurora Cannabis' Latest Debacle Couldn't Come at a Worse Time
International medical cannabis sales was one of only a few bright spots in Aurora's ugly Q1 results. Now that bright spot appears to be largely snuffed out, at least temporarily.
3 Reasons Canopy Growth Won't Be Profitable Anytime Soon
But the big Canadian cannabis producer has a safety net that most of its rivals don't.
3 Words AbbVie Investors Really Didn't Want to Hear
The latest ICER report doesn't paint AbbVie's new rheumatoid arthritis drug Rinvoq in as favorable a light as hoped.
3 Best Marijuana Stocks in November -- Are They Buys Now?
Not every pot stock floundered in November. These three delivered solid double-digit percentage gains.
Why Kodiak Sciences Stock Is Skyrocketing Today
Investors are excited about a big royalty deal for the biotech's lead pipeline candidate.
Here's My Top Stock to Buy in December
This small tech stock should benefit from an unstoppable trend: explosive growth in data.
Say Goodbye to Aurora Cannabis: These 2 Marijuana Stocks Have Much Better Prospects
Why bother with Aurora when these pot stocks have better revenue growth, better bottom lines, and better growth prospects?
3 Top Biotech Stocks to Buy in December
These biotech stocks cover all the bases, from great dividends to promising pipelines.
3 Stocks to Buy Ahead of the Next Market Crash
These stocks are great picks to own regardless of which turns the market takes.
Better Buy: Abbott Laboratories vs. Johnson & Johnson
Which stock wins in a matchup between these two healthcare giants?
Better Buy: Canopy Growth vs. Scotts Miracle-Gro
Which stock wins in a matchup between a top Canadian cannabis producer and a leading U.S. gardening supply company?
Why Akebia Therapeutics Stock Is Jumping Today
Momentum is continuing for the biotech after an announcement of positive clinical results and buying by key insiders earlier this month.
Why Evolent Health Shares Are Tanking Today
A major contract loss in Kentucky is weighing heavily on the managed-care stock.
Should Investors Worry About Johnson & Johnson's Eroding Moat?
J&J's competitive advantages aren't what they used to be. But does that change the appeal of the blue chip stock?
Why Aurora Cannabis' Surge Last Week Evaporated
The Canadian cannabis producer enjoyed a nice rebound -- but only a temporary one.
Why Editas Medicine Shares Jumped Today
A combination of several factors could be behind the biotech's big gain.